Samsung Biologics
207940 · KOSPI · Biotechnology / Contract Manufacturing
About the company
Samsung Biologics is a leading global contract development and manufacturing organization (CDMO) for biopharmaceutical products, including biosimilars and monoclonal antibodies. It operates large-scale biomanufacturing facilities in Incheon, South Korea, and serves major pharmaceutical companies worldwide. The company is a subsidiary of Samsung Group.
| Exchange | KOSPI |
| Ticker | 207940 |
| Sector | Biotechnology / Contract Manufacturing |
| Indicative market cap USD | $36.00B |
| Website | Visit website |
Live quote
Loading live price…
| Market cap | |
| Day range | |
| 52-week range |
Where to buy
On its home market (KOSPI), it is accessible through global brokers that offer that exchange:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- Korea Exchange — official exchange listing
Availability information only — not a recommendation or an offer to buy. Confirm eligibility, fees and current availability with your broker.
Other companies in South Korea
Company data and any live price are indicative, may be delayed or inaccurate, and are for research only — not investment advice. Verify with the exchange, the company's filings and your broker.